Benjamin J. Hindson - 14 Dec 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
President and Chief Scientific Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson
Issuer symbol
TXG
Transactions as of
14 Dec 2022
Net transactions value
+$172,701
Form type
4
Filing time
16 Dec 2022, 15:46:47 UTC
Previous filing
23 Nov 2022
Next filing
24 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $172,701 +34,266 +16% $5.04* 251,979 14 Dec 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -34,266 -73% $0.000000 12,972 14 Dec 2022 Class A Common Stock 34,266 $5.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All of the shares subject to the option are fully vested and exercisable as of the date hereof.

Remarks:

President and Chief Scientific Officer